Retraction Note: Lycorine inhibits angiogenesis by docking to PDGFRα - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Withdrawal Notice: Lycorine's Role in Angiogenesis Inhibition via PDGFRα Interaction

  • By

  • Fei Lv

  • XiaoQi Li

  • Ying Wang

  • September 11, 2026

Share

  • 1

    The article titled 'Lycorine's Role in Angiogenesis Inhibition via PDGFRα Interaction' was retracted by BMC Cancer.

  • 2

    Retraction occurred due to post-publication concerns regarding data integrity presented in the article.

  • 3

    Figure 2b showed apparent overlap among multiple experimental conditions, raising questions about the data.

  • 4

    The authors did not respond to the concerns raised by the Editors regarding the article's data.

  • 5

    The Editors lost confidence in the article's data and conclusions, leading to the retraction.

Original Source(s)

Retraction Note: Lycorine inhibits angiogenesis by docking to PDGFRα

  • by Fei Lv, XiaoQi Li, Ying Wang

  • September 11, 2026

Related Content

Case Report: Donor-derived early T-cell precursor acute lymphoblastic leukemia following an allogeneic hematopoietic stem cell transplantation for pediatric severe aplastic anemia

Retraction Note: TWIST1 activates cancer stem cell marker genes to promote epithelial‑mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma

Case Report: Treatment of an unresectable mucoepidermoid carcinoma with osimertinib